Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:21 PM
Ignite Modification Date:
2025-12-24 @ 12:21 PM
NCT ID:
NCT00688961
Eligibility Criteria:
Inclusion Criteria:
* Subjects may be male or female and between the ages of 21 and 60,
* Non-smokers,
* Taking no medications, vitamin pills, nutritional supplements or herbal preparations.
Exclusion Criteria:
* Subjects may not have a history of allergic reactions to aspirin, fish or fish oils.
* Birth control pills are not allowed.
* Subject cannot have an allergy to aspirin or to non-steroidal anti-inflammatory drug (NSAID) such as ibuprofen (Motrin, Advil, others), naproxen (Aleve, Naprosyn, Anaprox, others), indomethacin (Indocin), or ketoprofen (Orudis KT, Orudis, Oruvail), nabumetone (Relafen), oxaprozin (Daypro), or tartrazine.
* Drinking more than three alcoholic beverages a day
* Having any of the following conditions:
* an ulcer or bleeding in the stomach,
* liver or kidney disease,
* bleeding or blood clotting disorder (e.g., hemophilia),
* congestive heart failure,
* fluid retention,
* heart disease,
* high blood pressure,
* gout,
* asthma,
* arthritis, or
* nasal polyps.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
60 Years
Study:
NCT00688961
Study Brief:
Protocol Section:
NCT00688961